Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Dec 19 2022

Dec 19, 2022 at 12:12 PM EST · Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE · Dec 19, 2022 at 12:12 PM EST · 4 pages · English

On 6ix: 6ix.com/news/press-release-dec-19-2022-3

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23 Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call

Release

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2022, titled "Dr. Reddy s successfully completes Phase 1 study ofDRL_TC, a proposed biosimilar of tocilizumab".

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Press Release Dec 16 2022Dec 16, 2022
Press Release Oct 11 2022Oct 11, 2022
Press Release Sep 07 2022Sep 7, 2022
Press Release Jul 27 2022Jul 27, 2022
Press Release Jul 22 2022Jul 22, 2022

Later from Dr. Reddy's Laboratories

Press Release Jan 13 2023Jan 13, 2023
Dr. Reddy's Laboratories Ltd. Press Release Jan 20 2023Jan 19, 2023
Press Release Jan 27 2023Jan 27, 2023
Press Release Feb 08 2023Feb 8, 2023
Dr. Reddy's Laboratories Ltd. Press Release Feb 27 2023Feb 26, 2023

All Dr. Reddy's Laboratories news releases

Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.

Follow Dr. Reddy's Laboratories